EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 12

Ensembl ID : ENSOMYG00000030167
Gene Symbol: MAP3K12
1 Cross references
179 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 13

Ensembl ID : ENSOMYG00000037341
Gene Symbol: SI:CH211-45C16.2
1 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 8

Ensembl ID : ENSOMYG00000038819
Gene Symbol: MAP3K8
1 Cross references
194 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSOMYG00000035083
Gene Symbol: MGLL
1 Cross references
202 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSOMYG00000047714
Gene Symbol: MGLL
1 Cross references
202 Possible Orthologues:

Motilin Receptor

Ensembl ID : ENSOMYG00000034813
Gene Symbol: MLNR
1 Cross references
174 Possible Orthologues:

Natriuretic Peptide Receptor 1a

Ensembl ID : ENSOMYG00000011071
Gene Symbol: NPR1A
1 Cross references
186 Possible Orthologues:

Natriuretic Peptide Receptor 1a

Ensembl ID : ENSOMYG00000018988
Gene Symbol: NPR1A
1 Cross references
187 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSOMYG00000031590
Gene Symbol: NPR3
1 Cross references
205 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSOMYG00000035643
Gene Symbol: NPR3
1 Cross references
206 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSOMYG00000005938
Gene Symbol: NTSR1
1 Cross references
198 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSOMYG00000007977
Gene Symbol: NTSR1
1 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).